Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stenzl

Showing results (51-60 of 925) with videos related to

Pageof 93
Sort By:
BJU International|July 1, 2015
Can we rely on lymphovascular invasion for determining the need for adjuvant chemotherapy in organ-confined bladder cancer?Georgios Gakis, Arnulf Stenzl
Wiener Medizinische Wochenschrift (1946)|September 30, 1984
[Pathology of advanced maxillary cancer following combined radiotherapy and surgical therapy]A Stenzl, H Kärcher
Advances in Experimental Medicine and Biology|June 5, 2004
Autologous muscle transfer for reconstruction of the lower urinary tractArnulf Stenzl, Milomir Ninkovic
Current Opinion in Urology|September 17, 2015
Considerations for orthotopic diversions in womenGeorgios Gakis, Arnulf Stenzl
Nature Reviews. Urology|May 12, 2010
Immunologic mechanisms in RCC and allogeneic renal transplant rejectionJens Bedke, Arnulf Stenzl
Expert Review of Anticancer Therapy|June 6, 2009
Should photodynamic diagnosis be standard practice for bladder cancer?Arnulf Stenzl, Stephan Kruck
Translational Andrology and Urology|February 12, 2020
Preservation of the bladder, but at what cost?Niklas Harland, Arnulf Stenzl
Nature Reviews. Urology|February 6, 2013
C-reactive protein in bladder cancer: where do we stand?Georgios Gakis, Arnulf Stenzl
The Journal of Urology|December 3, 2014
Role of 11C-choline positron emission tomography in prostate cancer recurrence--potential for delayed cure or just resetting the clock of the disease?Georgios Gakis, Arnulf Stenzl
Translational Andrology and Urology|August 9, 2019
Should every patient with muscle-invasive bladder cancer receive neoadjuvant chemotherapy?Moritz Maas, Arnulf Stenzl
Pageof 93

Showing results (51-60 of 925) with videos related to

Sort By:
Pageof 93
BJU International|July 1, 2015
Can we rely on lymphovascular invasion for determining the need for adjuvant chemotherapy in organ-confined bladder cancer?Georgios Gakis, Arnulf Stenzl
Wiener Medizinische Wochenschrift (1946)|September 30, 1984
[Pathology of advanced maxillary cancer following combined radiotherapy and surgical therapy]A Stenzl, H Kärcher
Advances in Experimental Medicine and Biology|June 5, 2004
Autologous muscle transfer for reconstruction of the lower urinary tractArnulf Stenzl, Milomir Ninkovic
Current Opinion in Urology|September 17, 2015
Considerations for orthotopic diversions in womenGeorgios Gakis, Arnulf Stenzl
Nature Reviews. Urology|May 12, 2010
Immunologic mechanisms in RCC and allogeneic renal transplant rejectionJens Bedke, Arnulf Stenzl
Expert Review of Anticancer Therapy|June 6, 2009
Should photodynamic diagnosis be standard practice for bladder cancer?Arnulf Stenzl, Stephan Kruck
Translational Andrology and Urology|February 12, 2020
Preservation of the bladder, but at what cost?Niklas Harland, Arnulf Stenzl
Nature Reviews. Urology|February 6, 2013
C-reactive protein in bladder cancer: where do we stand?Georgios Gakis, Arnulf Stenzl
The Journal of Urology|December 3, 2014
Role of 11C-choline positron emission tomography in prostate cancer recurrence--potential for delayed cure or just resetting the clock of the disease?Georgios Gakis, Arnulf Stenzl
Translational Andrology and Urology|August 9, 2019
Should every patient with muscle-invasive bladder cancer receive neoadjuvant chemotherapy?Moritz Maas, Arnulf Stenzl
Pageof 93